Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

被引：0
|
作者：
Timothy S. Bailey
Bruce W. Bode
Qianqian Wang
Alastair W. Knights
Annette M. Chang
机构：
[1] AMCR Institute,
[2] Atlanta Diabetes Associates Hospital,undefined
[3] Eli Lilly and Company,undefined
来源：
Diabetes Therapy | 2023年 / 14卷
关键词：
Continuous glucose monitoring; Time in range; Type 2 diabetes; Ultra rapid lispro;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 897
页数：14
相关论文
共 50 条
  • [21] Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
    Hideaki Jinnouchi
    Makoto Imori
    Hiroshi Nishiyama
    Takeshi Imaoka
    Diabetes Therapy, 2020, 11 : 2075 - 2088
  • [22] Time-in-range as a target in type 2 diabetes: An urgent need
    Saboo, Banshi
    Kesavadev, Jothydev
    Shankar, Arun
    Krishna, Meera B.
    Sheth, Shruti
    Patel, Vidisha
    Krishnan, Gopika
    HELIYON, 2021, 7 (01)
  • [23] Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
    Zhou-qin Feng
    Qing-yu Guo
    Wei Wang
    Yan-yu Yuan
    Xu-guang Jin
    Hui Zhou
    Jun Liu
    Hai-yan Lei
    Xin-yi Yang
    Jun Liu
    Bin Lu
    Jia-qing Shao
    Ping Gu
    Diabetology & Metabolic Syndrome, 13
  • [24] ULTRA RAPID LISPRO (URLI) DEMONSTRATES SIMILAR TIME IN TARGET RANGE TO LISPRO WITH THE MEDTRONIC MINIMED 670G HYBRID CLOSED-LOOP SYSTEM
    Carlson, A.
    Liu, R.
    Hardy, T.
    Boyd, J.
    Bergenstal, R.
    Morrett, S.
    Ignaut, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A85 - A86
  • [25] Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
    Feng, Zhou-qin
    Guo, Qing-yu
    Wang, Wei
    Yuan, Yan-yu
    Jin, Xu-guang
    Zhou, Hui
    Liu, Jun
    Lei, Hai-yan
    Yang, Xin-yi
    Liu, Jun
    Lu, Bin
    Shao, Jia-qing
    Gu, Ping
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [26] Effect of age on HbA1c, postprandial glucose control, and hypoglycaemia in patients with type 2 diabetes treated with Ultra Rapid Lispro (URLi) or Lispro: PRONTO-T2D
    Chang, A.
    Hardy, T.
    Zhang, Q.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S325 - S325
  • [27] Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study
    Bode, Bruce
    Garg, Satish
    Norwood, Paul
    Morales, Cristobal
    Hardy, Thomas
    Liu, Rong
    Ignaut, Debra
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (01) : 41 - 50
  • [28] Ultra Rapid Lispro (URLi) accelerates insulin lispro absorption and insulin action vs lispro in patients with type 2 diabetes
    Leohr, J.
    Dellva, M.
    Coutant, D.
    LaBell, E.
    Reddy, S.
    Bowerman, S.
    Heise, T.
    Andersen, G.
    Zijlstra, E.
    Hermanski, L.
    Nosek, L.
    Linnebjerg, H.
    DIABETOLOGIA, 2019, 62 : S381 - S381
  • [29] Ultra Rapid Lispro (URLi) demonstrates similar time in target range to Lispro with the Medtronic MiniMed 670G hybrid closed-loop system
    Bode, B.
    Carlson, A.
    Liu, R.
    Hardy, T.
    Boyd, J.
    Bergenstal, R.
    Morrett, S.
    Ignaut, D.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S327 - S327
  • [30] Ultra-rapid lispro (URLi) improves postprandial glucose control vs Humalog® (Lispro) in type 1 diabetes: PRONTO-T1D Study
    Klaff, Leslie
    Cao, Dachuang
    Dellva, Mary Anne
    Tobian, Janet
    Miura, Junnosuke
    Dahl, Dominik
    Bue-Valleskey, Juliana
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
12345